Alzchem Group Ag · XETR:ACT
Alzchem — Q1 2023 Earnings Presentation
36 slides from Alzchem's earnings presentation, May 4, 2023
Slide 1: Agile Science Pure Results
AGILE SCIENCE PURE RESULTS
Slide 2: Q1 2023 Analyst Presentation
Q1 2023 ANDREAS NIEDERMAIER, CEO DR. GEORG WEICHSELBAUMER, CSO MAY 4, 2023
Slide 3: Disclaimer
DISCLAIMER CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements about the business, financial condition and earnings performance of the Alzchem Group. These statements are based on assumptions and projections resting upon currently available info
Slide 4: Agenda — Executive Summary
AGENDA — ANALYST PRESENTATION Q1 2023 Executive Summary
Slide 5: Highlights
HIGHLIGHTS Sales and EBITDA increased, successful inventory reduction level in EBITDA margin positive again Sales significantly dil EBITDA above prior Operating cash flow above previous year’s So year but slight decline £03 and free cash flow are < —, approved Specialty Chemicals capacities not only
Slide 6: Our Path to Climate Neutrality
OUR PATH TO CLIMATE NEUTRALITY
Slide 7: Sustainability Indicators
SUSTAINABILITY INDICATORS At a glance UNTIL 2030 ~75% 1. MILESTONES ~90.000t CO, -SAVING = 3 O COST SAVINGS ~€ 6mn ANNUAL mn INVESTMENT TARGET UNTIL 2033 CO,-SAVING CO,-EMISSIONS S
Slide 8: Our Milestones
© Alzchem Group AG. OUR MILESTONES VAS "Net Zero" is at the heart of our climate roadmap 0 The remaining two thirds of our CO, emissions amounting to approx. 110,000 tonnes (basis 2022) are to be reduced in the future. 100 ] Raq, We see these so-called Scope 1 emissions as the central adjusting scre
Slide 9: All in all: A green future with Alzchem
ALL IN ALL: I XY A green future with Alzchem - it's worth it. For everyone! Alzchem can already keep the CO, footprint of its own products comparatively low. With the Alzchem climate roadmap, the path to Net Zero - i.e. to an almost perfect circular economy in the area of Scope 1 emissions - has bee
Slide 10: Financial Overview
FINANCIAL OVERVIEW Sales growth despite still challenging market situation SALES (in M€) Volume EBITDA (in M€) 71 Price EBITDA margin (in %) 13.2% Currency Earnings per Share (in €) 0.76 | challenging environment driven by ti availability of transport opt situatic the energy market seems to stabiliz
Slide 11: Agenda — Business and financial details
AGENDA — ANALYST PRESENTATION Q1 2023 ll. Business and financial details
Slide 12: Basics & Intermediates
NITRALZ® CBerlka’ iG al BASICS & INTERMEDIATES The "Basics & Intermediates" segment comprises the production of basic and intermediate products that are marketed as independent products for example in agriculture, steel production and the automotive sector and as raw materials for the manufacture of
Slide 13: Basics & Intermediates Segment
BASICS & INTERMEDIATES SEGMENT (in Mé€) Sales and EBITDA almost at previous year’s level SALES ANALYSIS Qi Q2. Q3) Q4 QI Q2 Q3 QA 2021 2021 2021 2021 2022 2022 2022 2022 2023 el but \ and NITRA (re _, Qi Q2) Q3) Q4)- QI Q2- QB: 4 1-3 1-3 2021 2021 2021 2021 2022 2022 2022 2022 2023 2022 = 2023
Slide 14: Specialty Chemicals
a Pa ( CREAMINO [rmex' Bioselect? DYHARD #88 Creapure“ SPECIALTY CHEMICALS The "Specialty Chemicals" segment produces and sells high-quality growth products in the area of specialty chemicals.
Slide 15: Specialty Chemicals Segment
SPECIALTY CHEMICALS SEGMENT (in Mé€) Sales at all time high due to volume and price increases Qi Q2. Q3) Q4 QI Q2 Q3 QA 2021 2021 2021 2021 2022 2022 2022 2022 2023 _ Qi Q2. Q3) Q4 QI Q2 Q3 QA 2021 2021 2021 2021 2022 2022 2022 2022 2023 1-3 2022 1-3 2023 1-3 2022 1-3 2023 SALES ANALYSIS Ih p gin in
Slide 16: Other & Holding
The "Other & Holding" segment offers infrastructure and energy supply services at our locations for the chemicals segments and for external customers. Gti. “a OTHER & HOLDING
Slide 17: Other & Holding Segment
OTHER & HOLDING SEGMENT (in me) Development of services in line with 2022 >. Qi Q2 Q3 Q4 QI Q2. Q3 4 2021 2021 2021 2021 2022 2022 2022 2022 2023 COMMENTS -0.1 Qi Q2. Q3) Q4 QI Q2 Q3 QA 1-3 1-3 2021 2021 2021 2021 2022 2022 2022 2022 2023 2022 2023
Slide 18: Balance Sheet
BALANCE SHEET (in mé€) Increase of balance sheet total and equity ratio Equit 194.3 Other non-current assets ay 12.4 Deferred taxes for pension provision Other non-current liabilities 120.0 Inventories Pension provision Trade receivables 1321 1077 MEO (Other current assets 31.12.2022 31.03.2023 31.1
Slide 19: Cashflow
CASHFLOW (in m€) Operating cash flow and free cash flow positive again no moni
Slide 20: Implementing Operating Targets
IMPLEMENTING OPERATING TARGETS Focus on the key growth drivers and sustainability IMPROVEMENT GROWTH SUSTAINABILITY * Raw material price increases at * Volume growth and full utilization of 4 + Vision 0 accidents and 0 waste least passed on to the market realized capex (Creapure®, : f a Wa ' * Imple
Slide 21: Outlook 2023
OUTLOOK 2023 (in Mé€) Positive sales and EBITDA development forecasted for 2023 2022 FC 2023 slight growth up to 590.0 ME COMMENTS * Outlook 2023 from annual statements 2022 confirmed * The Outlook is based on the following assumptions: slight growth up to 70.0 ME Ukr r further interruptions Segment
Slide 22: Financial Calendar
© Alzchem GrBtipAGgMay 2 FINANCIAL CALENDAR* Upcoming dates “subject to change MAY 11 MAY 16 AUG 3 SEP 18 — 20 SEP 18 — 23 OCT 26 NOV 15 NOV 27 — 29 2023 2023 2023 2023 2023 2023 2023 2023 me Annual General Meeting 2023 Frihjahrskonferenz 2023 Half-Year Financial Report 2023 Berenberg and Goldman Sa
Slide 23: Investor Relations
alzchem group Investor Relations T +49 8621 86-2888 F +49 8621 86-502888 ir@alzchem.com
Slide 24: Agenda — Appendix
AGENDA — ANALYST PRESENTATION Q1 2023
Slide 25: Balance Sheet
© Alzchem Group AG / May 2023 BALANCE SHEET Alzchem Group -ALZCHEM GROUP (IN TE) 31.12.2022 31.03.2023 Deviation ALZCHEM GROUP (IN TE) 31.12.2022 31.03.2023 Deviation intangible aesete 2,95 2,997 2 15% Share capital 101,763 101,763 Tangible assets 181526 179,266 -2,260 “1.2% RETAINED EARNINGS (+) /
Slide 26: Pension Accounting (IFRS)
PENSION ACCOUNTING (IFRS) Alzchem Group (M€) IN FINANCIAL PENSION SERVICE NET INTEREST PENSION STATEMENT PROVISION costs PAYMENTS 31.12.2022 FINAN RESULT BALANCE SHEET P&L CASHFLOW, Adjustment of market interest rate from ho > 3. increasing impact on provision Stable development of expected pension
Slide 27: Income Statement
© Alzchem Group AG / May 2023 INCOME STATEMENT Alzchem Group ALZCHEM GROUP (NTE) wn mon nos m0 essai eaton( Revenue 129395 140,435 139,193 133,200 150,432 21,037 16% Increase (+) / Decrease (-) ininventories of finished goods and workin progress 14144 14467-1959 4,459 76 13.228 -94% Other income 407
Slide 28: Income Statement
© Alzchem Group AG / May 2023 INCOME STATEMENT Alzchem Group ALZCHEM GROUP (IN TE) a oes Deviation (209) Revenue 129395 150,432 2037 «16.3% Increase (+) / Decrease (-) in inventories of finished goods and work in progress 14,144 916 ~13,228 93.5% Other income 4070 5574 1504 37.0% Raw materials and c
Slide 29: Cashflow Statement
© Alzchem Group AG / May 2023 CASHFLOW STATEMENT Alzchem Group Qi CASHFLOW (IN M€) 2022 Consolidated earnings before taxes 11,343 Depreciation on fixed and intangible assets 6305 Decrease in pension provisions “513 Loss (+) / Profit (-} from the sale of non-current assets =10 Other non-cash income {
Slide 30: Segment Overview by Quarter
SEGMENT OVERVIEW BY QUARTER AX Alzchem Group v SALES 2021 2023 a 2 @ a Q3 Q4 QA 2 OB _ —Q4_beviation PY (QN) SALES Te Te Te Te Te Te Te Te Te Te Te % Basics & Intermediates 41,070 45,178 42,465 47,561 59,557 52,614 57,337 “105 0% Specialty Chemicals 56,775 59,330 47,116 57,279 72,967 73,902 85,783 2
Slide 31: Executive Team
EXECUTIVE TEAM Alzchem Group AG me n- om : fem > DR. GEORG WEICHSELBAUMER CSO BEI ALZCHEM SEIT 2012 RESSORTVERANTWORTUNG. Marketing, Vertrieb, Innovationsmanagement & Verfahrensentwicklung, F&E, Produktsicherheit /-zulassung ANDREAS NIEDERMAIER CEO BEI ALZCHEM SEIT 1999 RESSORTVERANTWORTUNG Finanzen
Slide 32: Alzchem Group Locations
ALZCHEM GROUP LOCATIONS Production sites and sales companies COVENTRY (UK) ‘up AG / May 2023 SHANGHAI (CN) Pa ATLANTA (USA) © Alzchem Gri
Slide 33: Verbund — Fully Integrated Business Model
© Alzchem Group AG / May 2023 “VERBUND” — FULLY INTEGRATED BUSINESS MODEL ms Benefits of the “Verbund” system approach Segment Specialty Chemicals Segment Basics & Inter- mediates ‘Agriculture CYAN- DICYAN- AMIDE DIAMIDE vw CALCIUM CYANAMIDE CALCIUM CARBIDE tw Infrastructure cere CARBON ENERGY BENEF
Slide 34: Our Products and Markets
2023 © Alzchem Group AG / May OUR PRODUCTS AND MARKETS Successful with proven and new products in various industries MAIN PRODUCTS DESCRIPTION ey END-MARKETS CREAMINO’ A feed additive for broilers and pigs Feed additive 008 Creapure’ Premium brand for creatine monohydrate as a food supplement in spo
Slide 35: Our Products and Markets
2023 © Alzchem Group AG / May OUR PRODUCTS AND MARKETS Successful with proven and new products in various industries n w = a < n ae a ta co Wi [= e OTHER & HOLDING \N MAIN PRODUCTS DESCRIPTION END-MARKETS an Calcium carbide-based mixtures for hot metal desulphurization Steel industry al Guanidine Sa
Slide 36: Key Share Data
© Alzchem Group AG / May 2023 KEY SHARE DATA Share Details as of May 2, 2023 SHARES OUTSTANDING. LAST CLOSING PRICE MARKET CAPITALIZATION TICKER WKN ISIN LISTING DESIGNATED SPONSOR 10,176,335 EUR 19.10 EUR 194.4m ACT A2YNT3 DEOOOA2YNT30 Frankfurt Stock Exchange — Prime Standard Baader Bank AG Oddo S